Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Day: July 6, 2007
-
By Baltazar Gomez — On June 26, 2007, Denmark-based 7TM Pharma A/S announced the grant of United Kingdom patents covering the use of the Obinepitide and TM30339 for treating obesity. In 7TM Pharma’s statement, CEO Mette Kirstine Agger said the patents demonstrate the strength of 7TM Pharma’s patent position in the obesity area…
-
By Donald Zuhn — Applied Nanoscience Inc. announced today (July 6, 2007) that it has entered into a settlement agreement with NanoScale Coroporation. The agreement ends the lawsuit NanoScale filed against Applied Nanoscience, Emergency Filtration Products, Inc., Applied Nanoscience President Thomas K. Allen, and Emergency Filtration Products President and CEO Douglas K. Beplate,…
Patent Docs 